Update on Prepregnancy Maternal Obesity: Birth Defects and Childhood Outcomes

Noha Iessa1, Anick Bérard1

  • 1Faculty of Pharmacy, University of Montreal, Montreal, Québec, Canada; Research Center, CHU Sainte-Justine, Montreal, Québec, Canada.

Insights

Pre-pregnancy obesity significantly increases risks for birth defects and adverse outcomes for offspring. This review summarizes recent research on maternal obesity and its impact on pregnancy and child health.

Area of Science:

  • Reproductive Health
  • Pediatric Health
  • Public Health

Background:

  • Obesity is a global health epidemic affecting over 20% of pregnancies.
  • Pre-pregnancy obesity is linked to adverse birth outcomes, including neural tube defects, macrosomia, and fetal death.
  • Offspring of obese mothers face long-term risks, such as asthma.

Purpose of the Study:

  • To summarize recent studies and meta-analyses on maternal obesity and birth outcomes.
  • To explore potential biological mechanisms linking obesity to adverse pregnancy and infant health.
  • To identify areas for future research in maternal obesity and offspring health.

Main Methods:

  • Systematic review of recent scientific literature.
  • Analysis of meta-analyses focusing on obesity and pregnancy outcomes.
  • Exploration of proposed pathophysiological pathways.

Main Results:

  • Maternal obesity is associated with a higher incidence of major birth defects.
  • Increased rates of macrosomia and fetal demise are observed in pregnancies complicated by obesity.
  • Long-term health issues, including respiratory problems, are more prevalent in children born to obese mothers.

Conclusions:

  • Pre-pregnancy obesity poses significant risks to fetal development and long-term child health.
  • Understanding the mechanisms underlying these risks is crucial for developing effective interventions.
  • Further research is recommended to mitigate the adverse effects of maternal obesity on birth outcomes.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
325
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
343